Belden grants RSUs to EVP Brian Lieser

Lieser Brian reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Lieser Brian reported acquisition or exercise transactions in this Form 4 filing.

Belden Inc. reported that EVP and Chief Commercial Officer Brian Lieser received a grant of 3,641 restricted stock units tied to common stock on February 25, 2026. The RSUs vest 25% on February 25, 2027, 25% on February 25, 2028, and 50% on February 25, 2029. Lieser also indirectly holds 521.8845 shares of Belden common stock through the Belden Retirement Savings Plan as of this filing.

Insider Trade Summary

Grant/Award: 3,641 shares

Grant/Award 2 txns

Insider Lieser Brian

Role EVP - Chief Comm. Officer

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	3,641	$0.00	$0.00
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 32,152 shares (Direct); Common Stock — 521.8845 shares (Indirect, By 401(k) Plan)

Footnotes (2)

1. F1. Represents a grant of RSUs granted by the Company's Compensation Committee on February 25, 2026. 25% of the RSUs will vest on February 25, 2027, 25% of the RSUs will vest on February 25, 2028 and 50% of the RSUs will vest on February 25, 2029. Additional terms apply in the event of the holder's termination, death, disability or retirement.
2. F2. Represents the balance of shares of Belden Inc. common stock held in the Belden Retirement Savings Plan as of the date of this filing.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Belden (BDC) report for Brian Lieser?

Belden reported that EVP and Chief Commercial Officer Brian Lieser received a grant of 3,641 restricted stock units on February 25, 2026. These RSUs represent equity compensation rather than an open-market share purchase, following a structured multi-year vesting schedule approved by the company’s Compensation Committee.

How do Brian Lieser’s new RSUs at Belden (BDC) vest over time?

The 3,641 RSUs granted to Brian Lieser vest in stages over three years. 25% vest on February 25, 2027, another 25% on February 25, 2028, and the remaining 50% on February 25, 2029, with additional terms applying to termination, death, disability, or retirement.

Did Brian Lieser buy or sell Belden (BDC) shares in this Form 4?

This Form 4 shows an equity award, not an open-market trade. Brian Lieser acquired 3,641 restricted stock units as a grant, coded as a grant or award acquisition, with no reported share sales or purchases in the transaction summary for this filing.

What indirect Belden (BDC) holdings does Brian Lieser report?

Brian Lieser reports indirect ownership of 521.8845 shares of Belden common stock. These shares are held in the Belden Retirement Savings Plan as of the filing date, reflecting retirement-plan holdings rather than directly held trading shares in a brokerage or personal account.

What is Brian Lieser’s role at Belden (BDC) related to this Form 4?

Brian Lieser is Belden’s Executive Vice President and Chief Commercial Officer. The Form 4 records a compensation-related equity grant to him, structured as 3,641 restricted stock units with multi-year vesting, as approved and granted by the company’s Compensation Committee on February 25, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/27/2026 - 02:25 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Lieser Brian

(Last) (First) (Middle)

C/O BELDEN INC.

1 N. BRENTWOOD BLVD., 15TH FLOOR

(Street)

ST. LOUIS MO 63105

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
BELDEN INC. [ BDC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP - Chief Comm. Officer

3. Date of Earliest Transaction (Month/Day/Year)
02/25/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/25/2026		A		3,641(1)	A	$0	32,152	D
Common Stock								521.8845(2)	I	By 401(k) Plan

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents a grant of RSUs granted by the Company's Compensation Committee on February 25, 2026. 25% of the RSUs will vest on February 25, 2027, 25% of the RSUs will vest on February 25, 2028 and 50% of the RSUs will vest on February 25, 2029. Additional terms apply in the event of the holder's termination, death, disability or retirement.

2. Represents the balance of shares of Belden Inc. common stock held in the Belden Retirement Savings Plan as of the date of this filing.

	/s/ Brian E. Anderson, attorney-in-fact for Brian Lieser	02/27/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.